D'Onofrio Matthew J 4
4 · Evoke Pharma Inc · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
D'Onofrio Matthew J
Exec VP, Chief Bus. Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+100,000→ 100,000 totalExercise: $0.55Exp: 2032-02-01→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option shall vest at the rate of 1/48th of the original number of shares on each monthly anniversary of January 1, 2022, subject to the reporting person's continuous service to the issuer on each such vesting date.